UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTI

Their core work

Carol Davila University is Romania's leading medical university, contributing clinical expertise and patient data to European health research consortia. Their work spans elderly care and rehabilitation, infectious disease surveillance (including COVID-19 ICU monitoring), antimicrobial resistance prevention, and AI-driven chronic disease management. They bring real-world clinical settings and patient cohorts from Central and Eastern Europe — a region often underrepresented in EU health studies — making them a valuable partner for multi-site clinical validation.

What they specialise in

How they've shifted over time

Their early H2020 work (2015–2019) centered on clinical trials and patient rehabilitation — traditional medical university activities like glucocorticoid treatment studies (GLORIA) and virtual coaching for elderly rehab (vCare). From 2020 onward, a clear digital shift emerged: AI-driven risk prediction (WARIFA), real-time ICU surveillance (ENVISION), and digital integrated care platforms (PROCare4Life). Their most recent and largest project (REVERSE, EUR 1.25M) signals a move into antimicrobial resistance — a major EU health priority that could define their next phase.

Moving decisively toward digital health tools and antimicrobial resistance — two areas with strong EU funding momentum through Horizon Europe.

How they like to work

Carol Davila operates exclusively as a consortium participant — they have never coordinated an H2020 project. This positions them as a reliable clinical partner who contributes patient access, medical expertise, and CEE regional coverage without seeking project leadership overhead. With 130 unique partners across 30 countries, they are well-networked and comfortable in large international consortia, making them easy to integrate into new proposals.

Exceptionally broad network for a Romanian institution: 130 unique partners across 30 countries, built through 9 projects. This reach reflects their role as a go-to clinical partner representing the Central and Eastern European healthcare context in pan-European consortia.

What sets them apart

Carol Davila fills a specific gap in European health consortia: they provide clinical validation sites and patient cohorts from Romania, a country with high disease burden and underrepresentation in EU research. Their combination of traditional clinical medicine with growing AI/digital health capabilities makes them increasingly versatile. For consortium builders, they offer both geographic diversity (important for EU proposal scoring) and genuine medical expertise — not just a flag on the map.

Highlights from their portfolio

• REVERSE
  By far their largest project (EUR 1.25M, half their total H2020 funding), tackling antimicrobial resistance — one of the EU's top health priorities.
• ENVISION
  COVID-19 rapid-response project building AI-powered ICU surveillance tools, showing their ability to mobilize quickly for emerging health crises.
• WARIFA
  Combines machine learning with chronic disease prevention, representing their clearest move into AI-driven personalized health.